These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 19822807)

  • 1. Suppression of phosphoinositide 3-kinase prevents cardiac aging in mice.
    Inuzuka Y; Okuda J; Kawashima T; Kato T; Niizuma S; Tamaki Y; Iwanaga Y; Yoshida Y; Kosugi R; Watanabe-Maeda K; Machida Y; Tsuji S; Aburatani H; Izumi T; Kita T; Shioi T
    Circulation; 2009 Oct; 120(17):1695-703. PubMed ID: 19822807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The protective effects of exercise and phosphoinositide 3-kinase (p110alpha) in the failing heart.
    Owen KL; Pretorius L; McMullen JR
    Clin Sci (Lond); 2009 Mar; 116(5):365-75. PubMed ID: 19175355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of thrombospondin-2 causes age-related dilated cardiomyopathy.
    Swinnen M; Vanhoutte D; Van Almen GC; Hamdani N; Schellings MW; D'hooge J; Van der Velden J; Weaver MS; Sage EH; Bornstein P; Verheyen FK; VandenDriessche T; Chuah MK; Westermann D; Paulus WJ; Van de Werf F; Schroen B; Carmeliet P; Pinto YM; Heymans S
    Circulation; 2009 Oct; 120(16):1585-97. PubMed ID: 19805649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CELF-mediated alternative splicing is required for cardiac function during early, but not later, postnatal life.
    Terenzi F; Brimacombe KR; Penn MS; Ladd AN
    J Mol Cell Cardiol; 2009 Mar; 46(3):395-404. PubMed ID: 19073192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aging as a substrate of heart failure.
    Shioi T; Inuzuka Y
    J Cardiol; 2012 Dec; 60(6):423-8. PubMed ID: 23068289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The age related changes of nitric oxide and apoptosis in experiment.
    Tevzadze N; Gujabidze N; Giorgadze S; Rukhadze R
    Georgian Med News; 2009 Apr; (169):87-90. PubMed ID: 19430053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of insulin-like growth factor 1 and phosphoinositide 3-kinase in a setting of heart disease.
    McMullen JR
    Clin Exp Pharmacol Physiol; 2008 Mar; 35(3):349-54. PubMed ID: 18290876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific role of phosphoinositide 3-kinase p110alpha in the regulation of phagocytosis and pinocytosis in macrophages.
    Tamura N; Hazeki K; Okazaki N; Kametani Y; Murakami H; Takaba Y; Ishikawa Y; Nigorikawa K; Hazeki O
    Biochem J; 2009 Sep; 423(1):99-108. PubMed ID: 19604150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ageing of the heart.
    Roffe C
    Br J Biomed Sci; 1998 Jun; 55(2):136-48. PubMed ID: 10198472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-associated changes in cardiac gene expression after preconditioning.
    Liu L; Zhu J; Glass PS; Brink PR; Rampil IJ; Rebecchi MJ
    Anesthesiology; 2009 Nov; 111(5):1052-64. PubMed ID: 19858872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring the accumulation of lipofuscin in aging murine eyes by fluorescence spectroscopy.
    Mukherjee P; Bose S; Hurd AA; Adhikary R; Schönenbrücher H; Hamir AN; Richt JA; Casey TA; Rasmussen MA; Petrich JW
    Photochem Photobiol; 2009; 85(1):234-8. PubMed ID: 18764899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The transcription of the amyloid precursor protein and tryptophan 2,3-dioxygenase genes are increased by aging in the rat brain].
    Kálmán S; Pákáski M; Szucs S; Garab D; Domokos A; Zvara A; Puskás L; Bagdy G; Zelena D; Kálmán J
    Ideggyogy Sz; 2009 Sep; 62(9-10):326-32. PubMed ID: 19835274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new direction for cardiac regeneration therapy: application of synergistically acting epicardium-derived cells and cardiomyocyte progenitor cells.
    Winter EM; van Oorschot AA; Hogers B; van der Graaf LM; Doevendans PA; Poelmann RE; Atsma DE; Gittenberger-de Groot AC; Goumans MJ
    Circ Heart Fail; 2009 Nov; 2(6):643-53. PubMed ID: 19919990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Why do phosphatidylinositol kinases have so many isoforms?
    Min SH; Abrams CS
    Biochem J; 2009 Sep; 423(1):e5-8. PubMed ID: 19740077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential role of Pim-1 kinase in anesthetic-induced and ischemic preconditioning against myocardial infarction.
    Stumpner J; Redel A; Kellermann A; Lotz CA; Blomeyer CA; Smul TM; Kehl F; Roewer N; Lange M
    Anesthesiology; 2009 Dec; 111(6):1257-64. PubMed ID: 19934869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in connexin expression and the atrial fibrillation substrate in congestive heart failure.
    Burstein B; Comtois P; Michael G; Nishida K; Villeneuve L; Yeh YH; Nattel S
    Circ Res; 2009 Dec; 105(12):1213-22. PubMed ID: 19875729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defects in embryonic development of EGLN1/PHD2 knockdown transgenic mice are associated with induction of Igfbp in the placenta.
    Ozolins TR; Fisher TS; Nadeau DM; Stock JL; Klein AS; Milici AJ; Morton D; Wilhelms MB; Brissette WH; Li B
    Biochem Biophys Res Commun; 2009 Dec; 390(3):372-6. PubMed ID: 19683511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotection against spinal cord ischemia-reperfusion injury induced by different ischemic postconditioning methods: roles of phosphatidylinositol 3-kinase-Akt and extracellular signal-regulated kinase.
    Jiang X; Ai C; Shi E; Nakajima Y; Ma H
    Anesthesiology; 2009 Dec; 111(6):1197-205. PubMed ID: 19934862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased production of CXCL16 in experimental and clinical heart failure: a possible role in extracellular matrix remodeling.
    Dahl CP; Husberg C; Gullestad L; Waehre A; Damås JK; Vinge LE; Finsen AV; Ueland T; Florholmen G; Aakhus S; Halvorsen B; Aukrust P; Oie E; Yndestad A; Christensen G
    Circ Heart Fail; 2009 Nov; 2(6):624-32. PubMed ID: 19919988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.
    Mitrovic V; Seferovic P; Dodic S; Krotin M; Neskovic A; Dickstein K; de Voogd H; Böcker C; Ziegler D; Godes M; Nakov R; Essers H; Verboom C; Hocher B
    Circ Heart Fail; 2009 Nov; 2(6):523-31. PubMed ID: 19919976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.